Literature DB >> 2435259

Carcinoembryonic antigen and milk-fat globule protein staining of malignant mesothelioma and adenocarcinoma of the lung.

V Tron, J L Wright, A Churg.   

Abstract

Immunohistologic markers have been of considerable value in differentiating malignant mesothelioma from adenocarcinoma. Recently, staining for milk-fat globule (MFG) protein has been suggested as a useful diagnostic test for this separation, but subsequent reports have been conflicting, with some authors finding clearcut differences, while others showed similar marking of both tumor types. To examine this technique further, we studied lung carcinomas and mesotheliomas with commercially available anti-MFG, and compared these results with those obtained with anticarcinoembryonic antigen (CEA), a commonly used immunomarker of carcinoma. We found that carcinomas showed strong cytoplasmic staining for MFG and CEA; however, a greater percentage of carcinomas were more strongly positive for CEA than for MFG. Mesotheliomas did not, for the most part, stain strongly with either antibody. In addition, carcinomas from different hospitals stained differently for MFG, but not for CEA. We conclude that although strong cytoplasmic staining for MFG is a reasonably reliable indicator of carcinoma, CEA staining provides a better separation and is considerably easier to interpret in lung cancer specimens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435259

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Immunohistochemical expression of MAM-3 and MAM-6 antigens in salivary gland tumours.

Authors:  K Yamada; T Tanaka; M Mori; A Tsubura; S Morii; M Tsubone; C Ando; J Hilgers
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  Peritoneal mesothelioma.

Authors:  J H Anderson; C J Stewart; D T Hansell; J R Anderson
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

3.  Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1.

Authors:  M L Warnock; A Stoloff; A Thor
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

4.  Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.

Authors:  C L Collins; N G Ordonez; R Schaefer; C D Cook; S S Xie; J Granger; P L Hsu; L Fink; S M Hsu
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

5.  ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.

Authors:  C J O'Hara; J M Corson; G S Pinkus; R A Stahel
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

6.  Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases.

Authors:  C A Hartmann; H Schütze
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.